Table 3.
Prognostic factor | Univariate
|
Multivariate
|
||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p Value | Hazard ratio | 95% CI | p Value | |
Age > 58y | 1.51 | 1.42–1.62 | <0.001 | 1.41 | 1.32–1.51 | <0.001* |
| ||||||
Female sex | 1.024 | 0.95–1.10 | 0.516 | – | – | – |
| ||||||
Year of diagnosis quartile | ||||||
| ||||||
1986–2001 | – | Reference | – | – | – | |
| ||||||
2002–2004 | 1.62 | 1.42–1.86 | <0.001 | 1.74 | 1.52–1.99 | <0.001* |
| ||||||
2005–2006 | 1.35 | 1.18–1.55 | <0.001 | 1.35 | 1.18–1.55 | <0.001* |
| ||||||
2007–2008 | 1.20 | 1.04–1.39 | <0.001 | 1.15 | 1.01–1.33 | 0.049* |
| ||||||
Race | ||||||
| ||||||
White | – | Reference | – | – | – | |
| ||||||
Asian/Pacific Islander | 1.62 | 1.16–2.26 | 0.005 | 1.44 | 1.03–2.02 | 0.032* |
| ||||||
Black | 1.52 | 1.09–2.14 | 0.014 | 1.23 | 0.88–1.74 | 0.217 |
| ||||||
Other | 2.05 | 1.45–2.90 | <0.001 | 1.86 | 1.31–2.63 | <0.001* |
| ||||||
Regional disease | 1.62 | 1.51–1.75 | <0.001 | 1.55 | 1.44–1.66 | <0.001* |
| ||||||
Grade | ||||||
| ||||||
Well-differentiated | – | Reference | – | – | – | |
| ||||||
Moderately differentiated | 1.20 | 1.09–1.32 | <0.001 | 0.74 | 0.70–0.82 | <0.001* |
| ||||||
Poorly differentiated | 1.77 | 1.77–1.58 | <0.001 | 0.96 | 0.89–1.05 | 0.399 |
| ||||||
Undifferentiated | 1.67 | 1.28–2.18 | <0.001 | 1.40 | 1.25–1.56 | <0.001* |
| ||||||
Unknown | 1.44 | 1.32–1.58 | <0.001 | 1.26 | 0.96–1.63 | 0.089 |
| ||||||
Liver-directed procedure | ||||||
| ||||||
Resection or hepatic transplant | – | Reference | – | – | – | |
| ||||||
Ablation only | 1.52 | 1.67–1.92 | <0.001 | 1.79 | 1.66–1.93 | <0.001* |
| ||||||
Surgery, not otherwise specified | 1.79 | 1.23–1.86 | <0.001 | 1.39 | 1.13–1.71 | 0.002* |
| ||||||
Hepatocellular carcinoma | 1.69 | 1.23–2.32 | 0.001 | 1.65 | 1.20–2.28 | 0.002* |
Significant.